David Sacks Divests AI Stakes to Avoid Conflicts of Interest
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 11 2026
0mins
Should l Buy NVDA?
Source: Benzinga
- Conflict of Interest Management: David Sacks disclosed on a podcast that he divested his stakes in AI inference chip startup Groq and Elon Musk's xAI before assuming his role in the Trump administration to avoid potential conflicts of interest, demonstrating his commitment to transparency.
- Economic Loss Assessment: Venture capitalist Chamath Palihapitiya estimated that Sacks' economic sacrifice could exceed $1 billion, highlighting the significant financial cost associated with his public service, which may influence his future investment decisions.
- Company Valuation Growth: xAI recently raised funds at twice the valuation of the previous round, indicating strong performance in the AI sector despite Sacks' divestment, which could attract more investor interest in the company.
- Media Response: Sacks defended his divestment amid media scrutiny, emphasizing that he is not profiting from his government position but rather acting to maintain public trust, a move that could enhance his reputation in political circles.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NVDA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NVDA
Wall Street analysts forecast NVDA stock price to rise
41 Analyst Rating
39 Buy
1 Hold
1 Sell
Strong Buy
Current: 184.890
Low
200.00
Averages
264.97
High
352.00
Current: 184.890
Low
200.00
Averages
264.97
High
352.00
About NVDA
NVIDIA Corporation is a full-stack computing infrastructure company. The Company is engaged in accelerated computing to help solve the challenging computational problems. The Company’s segments include Compute & Networking and Graphics. The Compute & Networking segment includes its Data Center accelerated computing platforms and artificial intelligence (AI) solutions and software; networking; automotive platforms and autonomous and electric vehicle solutions; Jetson for robotics and other embedded platforms, and DGX Cloud computing services. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating industrial AI and digital twin applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nvidia Reports Record Earnings but Stock Falls
- Record Earnings: Nvidia reported a record revenue of $68.1 billion, up 73% year-over-year, with data center revenue soaring 75% to $62.3 billion, highlighting its strong demand and leadership in the AI market.
- Stock Reaction: Despite beating earnings expectations, Nvidia's stock fell approximately 5.5% post-earnings, marking its worst single-day drop since April 2025, reflecting market concerns over future AI investment returns.
- Expectation Issues: Analysts noted that Nvidia faces not a numbers problem but an expectations problem, as investors are anxious about whether AI infrastructure spending can remain high, leading to stock volatility.
- Strategic Direction: Nvidia aims to reduce inference costs to one-tenth of Blackwell through the Rubin platform, attracting major cloud providers to adopt its new technology, underscoring its strategic importance and competitive edge in the AI inference market.
See More
NVIDIA Partners with Industry Leaders to Build AI-Native 6G Networks
- Global Collaboration Initiative: NVIDIA, along with industry leaders such as Booz Allen, BT Group, and Cisco, commits to building AI-native, open, and secure 6G networks, aiming to advance the future of global connectivity while ensuring infrastructure is intelligent and resilient.
- Technological Transformation: By embedding AI across the radio access network (RAN), edge, and core, 6G networks will enable real-time intelligence and rapid innovation to meet increasing demands for security and trust, thereby driving infrastructure buildout in the telecommunications sector.
- Foundation for Economic Growth: BT Group CEO Allison Kirkby noted that connectivity is the backbone of economic growth, and this collaboration will lay the groundwork for a future ecosystem that is intelligent, sustainable, and secure, ensuring 6G technologies unlock new capabilities built on the strengths of 5G.
- International Leadership Position: U.S. Assistant Secretary of Commerce Arielle Roth emphasized that leadership in 6G is critical for national economic prosperity and global competitiveness, with the formation of this international industry coalition showcasing the U.S. and its allies' lead in next-generation technology.
See More
Investment Opportunities in Blue-Chip Stocks Amid Market Volatility
- Deere & Co. Strong Performance: Deere & Co. (NYSE: DE) has seen a 35% stock price increase this year by investing in autonomous tractors and AI technologies, successfully pivoting to a tech company, although it pulled back 5% last week due to tariff concerns.
- GE Vernova Growth Potential: GE Vernova (NYSE: GEV) shares are up 34%, and with its diverse energy generation capabilities, it is expected to benefit from the rising energy demand driven by AI, despite its high P/E ratio of 50.
- Microsoft's Market Challenges: Microsoft (NASDAQ: MSFT) has faced nearly a 30% pullback amid the AI-driven software sell-off; however, its cloud infrastructure and 27% stake in OpenAI still provide strong growth potential.
- Investor Focus on Blue-Chip Stocks: Although Deere & Co. was not recommended as a top investment by The Motley Fool, its potential in AI and market position make it worth considering, especially following the current market pullback.
See More
AI Cryptocurrency Kite Surges 140% in 90 Days: Is It a Buy?
- Market Performance: Kite (CRYPTO: KITE) has surged 140% over the past 90 days, now boasting a market cap of nearly $450 million, positioning itself among the top 100 cryptocurrencies globally, indicating strong momentum in the AI crypto sector.
- Funding Support: Kite secured $18 million in financing from PayPal Ventures and venture capital firm General Catalyst, reflecting confidence from high-profile investors in its future growth, which could enhance its technological and market expansion.
- Blockchain Infrastructure: Kite claims to be the 'first AI payment blockchain,' designed specifically for the autonomous economy, providing the transactional infrastructure for AI agents, potentially positioning itself as a key player in future automated transactions.
- Investment Risks: Despite Kite's impressive performance, many AI cryptocurrencies have faced significant price crashes after initial hype, necessitating cautious evaluation from investors regarding its long-term sustainability and market volatility.
See More
S&P 500 Posts Seventh Consecutive Monthly Gain
- Historical Performance Analysis: The S&P 500 index achieved a seven-month consecutive gain from May to November 2025, a phenomenon that has occurred only 21 times in the past century, indicating strong market performance; however, future 12-month returns may fall below long-term averages.
- Return Rate Statistics: In the last 20 instances of seven consecutive months of gains, the S&P 500 rose 70% of the time in the following 12 months, but the average return was only 7.2%, with a median even lower at 5.7%, highlighting the risk of mean reversion.
- Long-Term Trend Comparison: Compared to the S&P 500's long-term performance, the probability of the index rising 12 months later is 69.2%, with an average return of 8.1%, which starkly contrasts with the lower returns following a seven-month winning streak.
- Cautious Investment Advice: Despite the recent strong performance of the S&P 500, analysts advise investors to be cautious when considering purchases, as the current market environment may lead to lower-than-expected future returns, with recommendations for stocks that show greater potential.
See More
Bristol Myers Squibb: A High Dividend Investment Opportunity
- Dividend Yield Advantage: Bristol Myers Squibb currently offers a 4% dividend yield, significantly higher than the S&P 500's 1.1% and the pharmaceutical sector's average of 1.7%, making it an attractive option for income-seeking investors.
- Market Competition and Opportunities: Despite the fierce competition and high costs of drug development in the pharmaceutical industry, Bristol Myers Squibb's focus on cardiovascular, cancer, and immune-related medicines presents significant market opportunities, especially as GLP-1 weight-loss drugs capture investor attention.
- Stock Price Pullback and Recovery Potential: The company's stock is approximately 25% below its late 2022 highs, providing investors with an opportunity to benefit from potential price recovery while enjoying a high dividend yield, with a payout ratio of 70% that is not overly concerning.
- Patent Expiration and Development Outlook: While Bristol Myers Squibb's Opdivo cancer drug will lose patent protection in 2028, the company is exploring alternative delivery methods to extend patent protections, and its development pipeline includes other drugs, demonstrating its capability to manage patent expirations effectively.
See More
Nvidia Reports Record Earnings but Stock Falls
- Record Earnings: Nvidia reported a record revenue of $68.1 billion, up 73% year-over-year, with data center revenue soaring 75% to $62.3 billion, highlighting its strong demand and leadership in the AI market.
- Stock Reaction: Despite beating earnings expectations, Nvidia's stock fell approximately 5.5% post-earnings, marking its worst single-day drop since April 2025, reflecting market concerns over future AI investment returns.
- Expectation Issues: Analysts noted that Nvidia faces not a numbers problem but an expectations problem, as investors are anxious about whether AI infrastructure spending can remain high, leading to stock volatility.
- Strategic Direction: Nvidia aims to reduce inference costs to one-tenth of Blackwell through the Rubin platform, attracting major cloud providers to adopt its new technology, underscoring its strategic importance and competitive edge in the AI inference market.
See More
NVIDIA Partners with Industry Leaders to Build AI-Native 6G Networks
- Global Collaboration Initiative: NVIDIA, along with industry leaders such as Booz Allen, BT Group, and Cisco, commits to building AI-native, open, and secure 6G networks, aiming to advance the future of global connectivity while ensuring infrastructure is intelligent and resilient.
- Technological Transformation: By embedding AI across the radio access network (RAN), edge, and core, 6G networks will enable real-time intelligence and rapid innovation to meet increasing demands for security and trust, thereby driving infrastructure buildout in the telecommunications sector.
- Foundation for Economic Growth: BT Group CEO Allison Kirkby noted that connectivity is the backbone of economic growth, and this collaboration will lay the groundwork for a future ecosystem that is intelligent, sustainable, and secure, ensuring 6G technologies unlock new capabilities built on the strengths of 5G.
- International Leadership Position: U.S. Assistant Secretary of Commerce Arielle Roth emphasized that leadership in 6G is critical for national economic prosperity and global competitiveness, with the formation of this international industry coalition showcasing the U.S. and its allies' lead in next-generation technology.
See More
Investment Opportunities in Blue-Chip Stocks Amid Market Volatility
- Deere & Co. Strong Performance: Deere & Co. (NYSE: DE) has seen a 35% stock price increase this year by investing in autonomous tractors and AI technologies, successfully pivoting to a tech company, although it pulled back 5% last week due to tariff concerns.
- GE Vernova Growth Potential: GE Vernova (NYSE: GEV) shares are up 34%, and with its diverse energy generation capabilities, it is expected to benefit from the rising energy demand driven by AI, despite its high P/E ratio of 50.
- Microsoft's Market Challenges: Microsoft (NASDAQ: MSFT) has faced nearly a 30% pullback amid the AI-driven software sell-off; however, its cloud infrastructure and 27% stake in OpenAI still provide strong growth potential.
- Investor Focus on Blue-Chip Stocks: Although Deere & Co. was not recommended as a top investment by The Motley Fool, its potential in AI and market position make it worth considering, especially following the current market pullback.
See More
AI Cryptocurrency Kite Surges 140% in 90 Days: Is It a Buy?
- Market Performance: Kite (CRYPTO: KITE) has surged 140% over the past 90 days, now boasting a market cap of nearly $450 million, positioning itself among the top 100 cryptocurrencies globally, indicating strong momentum in the AI crypto sector.
- Funding Support: Kite secured $18 million in financing from PayPal Ventures and venture capital firm General Catalyst, reflecting confidence from high-profile investors in its future growth, which could enhance its technological and market expansion.
- Blockchain Infrastructure: Kite claims to be the 'first AI payment blockchain,' designed specifically for the autonomous economy, providing the transactional infrastructure for AI agents, potentially positioning itself as a key player in future automated transactions.
- Investment Risks: Despite Kite's impressive performance, many AI cryptocurrencies have faced significant price crashes after initial hype, necessitating cautious evaluation from investors regarding its long-term sustainability and market volatility.
See More
S&P 500 Posts Seventh Consecutive Monthly Gain
- Historical Performance Analysis: The S&P 500 index achieved a seven-month consecutive gain from May to November 2025, a phenomenon that has occurred only 21 times in the past century, indicating strong market performance; however, future 12-month returns may fall below long-term averages.
- Return Rate Statistics: In the last 20 instances of seven consecutive months of gains, the S&P 500 rose 70% of the time in the following 12 months, but the average return was only 7.2%, with a median even lower at 5.7%, highlighting the risk of mean reversion.
- Long-Term Trend Comparison: Compared to the S&P 500's long-term performance, the probability of the index rising 12 months later is 69.2%, with an average return of 8.1%, which starkly contrasts with the lower returns following a seven-month winning streak.
- Cautious Investment Advice: Despite the recent strong performance of the S&P 500, analysts advise investors to be cautious when considering purchases, as the current market environment may lead to lower-than-expected future returns, with recommendations for stocks that show greater potential.
See More
Bristol Myers Squibb: A High Dividend Investment Opportunity
- Dividend Yield Advantage: Bristol Myers Squibb currently offers a 4% dividend yield, significantly higher than the S&P 500's 1.1% and the pharmaceutical sector's average of 1.7%, making it an attractive option for income-seeking investors.
- Market Competition and Opportunities: Despite the fierce competition and high costs of drug development in the pharmaceutical industry, Bristol Myers Squibb's focus on cardiovascular, cancer, and immune-related medicines presents significant market opportunities, especially as GLP-1 weight-loss drugs capture investor attention.
- Stock Price Pullback and Recovery Potential: The company's stock is approximately 25% below its late 2022 highs, providing investors with an opportunity to benefit from potential price recovery while enjoying a high dividend yield, with a payout ratio of 70% that is not overly concerning.
- Patent Expiration and Development Outlook: While Bristol Myers Squibb's Opdivo cancer drug will lose patent protection in 2028, the company is exploring alternative delivery methods to extend patent protections, and its development pipeline includes other drugs, demonstrating its capability to manage patent expirations effectively.
See More
